Thermoplastic Elastomers in Medical Devices Market Report 2026

The thermoplastic elastomers in medical devices market size has grown strongly in recent years. It will grow from $2.96 billion in 2025 to $3.15 billion in 2026 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to rising demand for flexible catheter and tubing materials, increasing replacement of PVC with biocompatible elastomers, growth in minimally invasive surgical procedures, expansion of medical device manufacturing activities, increasing adoption of wearable healthcare devices.

The thermoplastic elastomers in medical devices market size is expected to see strong growth in the next few years. It will grow to $4.07 billion by 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to growing investment in sustainable medical polymers, rising demand for smart and connected wearable medical devices, increasing use of advanced overmolding and co-injection technologies, expansion of home healthcare and remote patient monitoring, growing innovation in high performance medical grade thermoplastic elastomers. Major trends in the forecast period include increasing demand for biocompatible and sterilization-compatible thermoplastic elastomers in medical devices, rising adoption of soft-touch thermoplastic elastomers for wearable medical equipment, growing use of recyclable and latex-free elastomer materials in healthcare manufacturing, expanding integration of antimicrobial thermoplastic elastomers in medical components, increasing development of lightweight and flexible thermoplastic elastomers for minimally invasive medical devices.

The rising adoption of minimally invasive aesthetic procedures is expected to propel the growth of the thermoplastic elastomers (TPE) market in medical devices. Minimally invasive aesthetic procedures, including dermal fillers, botulinum toxin injections, and laser-based treatments, are increasingly preferred because they provide cosmetic enhancements with minimal downtime, reduced discomfort, and lower risk compared to surgical alternatives. These procedures commonly depend on advanced delivery systems, such as syringes, catheters, and flexible tubing, where material performance is highly important. Thermoplastic elastomers play a significant role in supporting these applications by offering flexibility, soft-touch properties, biocompatibility, and chemical resistance, ensuring precision, safety, and patient comfort during procedures. For instance, in July 2024, according to the American Society Of Plastic Surgeons, minimally invasive aesthetic procedures increased by 5%, reaching 25.35 million treatments in 2024 compared to 24.11 million in 2023. Therefore, the rising adoption of minimally invasive devices is driving the growth of the thermoplastic elastomers in medical devices market.

Leading companies operating in the thermoplastic elastomers in medical devices market are emphasizing technological advancement in polymer engineering, such as bio-based elastomer formulation, to achieve a competitive advantage. Bio-based elastomer formulation involves incorporating renewable, plant-derived raw materials into the molecular structure of polymers to lower carbon footprints while maintaining medical-grade performance. For instance, in January 2024, Avient Corporation introduced versaflex hc bio bt218. This specialized grade includes bio-based content derived from plant resources, delivers excellent kink resistance for biopharmaceutical tubing, and maintains low extractable levels to protect sensitive fluids. These innovations enhance environmental sustainability and ensure patient safety during critical medical procedures. Therefore, technological advancements in the thermoplastic elastomers in medical devices market continue to drive high-performance healthcare solutions.

In July 2023, Arkema acquired Polytec PT for an undisclosed amount. Through this acquisition, Arkema seeks to expand its portfolio of high-performance thermoplastic elastomers and strengthen its position in advanced medical and healthcare applications by integrating specialized compounding capabilities. Polytec PT is a Germany-based provider of high-performance polymer compounds, including thermoplastic elastomers and engineering plastics tailored for medical devices, healthcare components, and regulated applications.

Major companies operating in the thermoplastic elastomers in medical devices market are BASF SE, Dow Inc., Asahi Kasei Corporation, Sibur Holding, Covestro AG, Mitsui Chemicals Inc., DSM-Firmenich, Celanese Corporation, Arkema S. A., Lubrizol Corporation, Kuraray Co. Ltd., Avient Corporation, Hexpol TPE AB, Kraton Corporation, Teknor Apex Company, RTP Company, Kraiburg TPE GmbH & Co. KG, Dynasol Group, Elastron TPE, LCY Chemical Corp.

North America was the largest region in the thermoplastic elastomers in medical devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the thermoplastic elastomers in medical devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the thermoplastic elastomers in medical devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The thermoplastic elastomers in medical devices market consists of sales of styrene block copolymers, thermoplastic polyurethanes, thermoplastic polyolefins, thermoplastic vulcanizates, and copolyester elastomers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.